about
Periorbital fat atrophy - an unfamiliar side effect of prostaglandin analoguesChanges to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprostBimatoprost in the treatment of eyelash hypotrichosisClinical presentation of a patient with localized acquired cutis laxa of abdomen: a case reportPeriorbital changes associated with prostaglandin analogs in Korean patients.A cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal featuresIncidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.Glaucoma management: relative value and place in therapy of available drug treatments.Iris and periocular adverse reactions to bimatoprost in Japanese patients with glaucoma or ocular hypertension.Iris heterochromia and unilateral eyelash hypertrichosisIn vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytesBimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse eventsIncidence of deepening of upper eyelid sulcus after topical use of tafluprost ophthalmic solution in Japanese patientsAnandamide-derived prostamide F2α negatively regulates adipogenesisEffects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.Prostaglandin-Associated Periorbital Lipodystrophy in Cosmetic Eyelid Surgery: A Novel Cause of Facial Asymmetry.Periorbital muscle atrophy associated with topical bimatoprost therapy.Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.A review of the use of latanoprost for glaucoma since its launch.Topical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophy.Tafluprost once daily for treatment of elevated intraocular pressure in patients with open-angle glaucoma.Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma.Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome.Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution.Topical prostaglandin analogue drugs inhibit adipocyte differentiation.Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomyChanges in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost.Magnetic Resonance Imaging of Optic Nerve Traction During Adduction in Primary Open-Angle Glaucoma With Normal Intraocular PressureAcute effects of glaucoma medications and benzalkonium chloride on pre-adipocyte proliferation and adipocyte cytotoxicity in vitro.In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat.Long-term Follow-up of Patients receiving Intraocular Pressure-lowering Medications as Cataract Surgery Candidates: A Case-control Study.Therapeutic potential of bimatoprost for the treatment of eyebrow hypotrichosis.Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.Effect of prostaglandin analogs on matrix metalloproteinases and tissue inhibitor of metalloproteinases in eyelid muscle specimens
P2860
Q28301055-21F36413-FF88-4F70-9D88-4F6DAB85D807Q28305613-BA06D23D-6921-4A7B-9CF7-12EFE8C02FF6Q33819865-2FCE5AE7-2872-42CA-A66A-0A4301498CC1Q33891137-ACA111A0-C795-4BDF-A7B1-3563140A6F11Q33913010-6B19E2B1-5FBE-41C6-A0E8-CDEFCE660ACBQ34708308-BEF12B43-B9A3-4C8F-B6FA-4FB542992D07Q34718491-48095DFD-F8BC-4F26-B761-824E88FA803AQ35079342-01D6736E-A9A9-49F6-B6E8-8D5CB7642515Q35682058-393F06D0-4EEB-4BC0-A0A0-02A296D65B34Q35843401-150EB2BB-5F46-4CA1-B795-6266D15F5B9BQ35860207-652BDE33-0370-4881-A88D-0DDA3B0E84F3Q36286983-3E146BCF-7B6E-43AC-88B7-12AB2B6BB732Q37027652-1F2426CC-224A-45BA-A484-D55BBF836041Q37095444-778C3E32-316C-4941-B6AE-54A46253E227Q37404274-82A353F6-6E85-42EB-B861-063821419169Q37451631-8A293FF0-2A72-4B1E-A154-07F32CB614A5Q37554099-7383740D-DC26-4027-B97A-71798094C44BQ37776497-9B8FCAA2-444B-4E95-AEF0-75A4BFC05917Q37986149-9D091FE3-DB2B-48BD-9C1A-0D42433D1791Q38040040-A65041D8-AA70-40FD-B317-24267AE8AD3EQ38072028-37D6B918-824C-41B9-857A-F3B280F87026Q38270686-CDB4F948-61D7-4829-88EE-FF7A838F003AQ38434738-2147306B-6B45-44B8-B16C-78BBAB7D8B37Q39458214-109C7654-1569-403C-9779-5EFAC3CC037BQ40070704-E550F94C-310D-4A78-A423-63F0A78DBAC4Q41072167-D63A818B-8214-40BA-98A5-560F29A4020CQ41431150-E22EBAB7-460D-4AF6-8F10-0438C760C459Q41483595-9764B9D4-1940-4495-9825-7583F9ED55F1Q45825927-AFA7F354-3A9C-4392-856B-38CCF1CDAAA6Q46111313-F512329D-F4FC-4911-83FD-6D3F0E7A6098Q47104053-BEAF6FBA-A5AB-4034-B0A5-0E09BD95B13FQ50348514-AB91AFE6-5481-49FC-B802-230F6D7FDFA2Q53130131-EBBDBB3D-2AD2-4811-B1C7-D259E182CEC8Q57815832-2FB8582A-8F44-4472-92B7-5CF8B123BC9A
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Periorbital changes associated with topical bimatoprost
@ast
Periorbital changes associated with topical bimatoprost
@en
Periorbital changes associated with topical bimatoprost
@nl
type
label
Periorbital changes associated with topical bimatoprost
@ast
Periorbital changes associated with topical bimatoprost
@en
Periorbital changes associated with topical bimatoprost
@nl
prefLabel
Periorbital changes associated with topical bimatoprost
@ast
Periorbital changes associated with topical bimatoprost
@en
Periorbital changes associated with topical bimatoprost
@nl
P2093
P1476
Periorbital changes associated with topical bimatoprost
@en
P2093
Cynthia L Grosskreutz
Louis R Pasquale
Mark P Hatton
Nurhan Torun
Theodoros Filippopoulos
P304
P356
10.1097/IOP.0B013E31817D81DF
P407
P577
2008-07-01T00:00:00Z